Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia
Naif Khalaf Alharbi, Suliman Alghnam, Abdullah Algaissi, Hind Albalawi, Mohammed W. Alenazi, Areeb M. Albargawi, Abdullah G. Alharbi, Abdulaziz Alhazmi, Ali Al Qarni, Ali Alfarhan, Hossam M. Zowawi, Hind Alhatmi, Jahad Alghamdi, Fayhan Alroqi, Yaseen M. Arabi, Anwar M. Hashem, Mohammed Bosaeed, Omar Aldibasi
doi: https://doi.org/10.1101/2021.01.28.21250598
Naif Khalaf Alharbi
1King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia
2King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
Suliman Alghnam
1King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia
2King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
Abdullah Algaissi
3Department of Medical Laboratories Technology, College of Applied Medical Sciences, Medical Research Center, Jazan University, Jazan 45142, Saudi Arabia
Hind Albalawi
1King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia
Mohammed W. Alenazi
1King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia
Areeb M. Albargawi
1King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia
Abdullah G. Alharbi
4King Fahad Specialized Hospital, Qassim, Saudi Arabia
Abdulaziz Alhazmi
3Department of Medical Laboratories Technology, College of Applied Medical Sciences, Medical Research Center, Jazan University, Jazan 45142, Saudi Arabia
Ali Al Qarni
5King Abdulaziz Hospital, Ministry of National Guard – Health Affairs, Alahsa, Saudi Arabia
Ali Alfarhan
6King Abdulaziz Medical City, Ministry of National Guard – Health Affairs, Riyadh, Saudi Arabia
Hossam M. Zowawi
2King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
Hind Alhatmi
6King Abdulaziz Medical City, Ministry of National Guard – Health Affairs, Riyadh, Saudi Arabia
Jahad Alghamdi
1King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia
2King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
Fayhan Alroqi
1King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia
2King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
6King Abdulaziz Medical City, Ministry of National Guard – Health Affairs, Riyadh, Saudi Arabia
Yaseen M. Arabi
1King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia
2King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
6King Abdulaziz Medical City, Ministry of National Guard – Health Affairs, Riyadh, Saudi Arabia
Anwar M. Hashem
7Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
8Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
Mohammed Bosaeed
1King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia
2King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
6King Abdulaziz Medical City, Ministry of National Guard – Health Affairs, Riyadh, Saudi Arabia
Omar Aldibasi
1King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia
2King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data are analysed and reported in the manuscript. Raw data are available by requesting it from the authors.
Posted January 31, 2021.
Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia
Naif Khalaf Alharbi, Suliman Alghnam, Abdullah Algaissi, Hind Albalawi, Mohammed W. Alenazi, Areeb M. Albargawi, Abdullah G. Alharbi, Abdulaziz Alhazmi, Ali Al Qarni, Ali Alfarhan, Hossam M. Zowawi, Hind Alhatmi, Jahad Alghamdi, Fayhan Alroqi, Yaseen M. Arabi, Anwar M. Hashem, Mohammed Bosaeed, Omar Aldibasi
medRxiv 2021.01.28.21250598; doi: https://doi.org/10.1101/2021.01.28.21250598
Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia
Naif Khalaf Alharbi, Suliman Alghnam, Abdullah Algaissi, Hind Albalawi, Mohammed W. Alenazi, Areeb M. Albargawi, Abdullah G. Alharbi, Abdulaziz Alhazmi, Ali Al Qarni, Ali Alfarhan, Hossam M. Zowawi, Hind Alhatmi, Jahad Alghamdi, Fayhan Alroqi, Yaseen M. Arabi, Anwar M. Hashem, Mohammed Bosaeed, Omar Aldibasi
medRxiv 2021.01.28.21250598; doi: https://doi.org/10.1101/2021.01.28.21250598
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (179)
- Cardiovascular Medicine (2603)
- Dermatology (218)
- Emergency Medicine (392)
- Epidemiology (12142)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4036)
- Geriatric Medicine (380)
- Health Economics (672)
- Health Informatics (2608)
- Health Policy (995)
- Hematology (359)
- HIV/AIDS (833)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (427)
- Neurology (3807)
- Nursing (208)
- Nutrition (567)
- Oncology (1991)
- Ophthalmology (578)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1100)
- Primary Care Research (443)
- Public and Global Health (6476)
- Radiology and Imaging (1379)
- Respiratory Medicine (867)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (52)
- Transplantation (185)
- Urology (165)